Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024
Shareholders at the upcoming Annual General Meeting.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
109.2 INR | -2.76% | +6.56% | +20.51% |
30/05 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
13/05 | Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+20.51% | 346M | |
+27.53% | 25.67B | |
-2.14% | 24.84B | |
+13.67% | 24.47B | |
-17.76% | 24.33B | |
+28.77% | 19.72B | |
+2.33% | 19.62B | |
+0.63% | 18.77B | |
+40.18% | 17.65B | |
-6.67% | 15.33B |